Uses whole-exome sequencing and multi-omic approaches to identify genetic contributors to Alzheimer's disease, particularly in families with high disease burden. Prioritizes candidate genes through transcriptomic analysis and tests their function in iPSC-derived neurons, microglia, and three-dimensional cellular models.